Ads
related to: Keytruda- Unique Therapy
Get Information At The
Physician Site
- Peer Videos
Watch Videos Sharing
Clinical And Patient Experiences
- Patient Support
Complete Patient Support
And Product Information
- Mechanism Of Action
Details About Therapy
MOA
- Dosing & Administration
Get Recommended
Dosing
- Safety Information
Review Key Safety
Information
- Unique Therapy
Search results
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 20 hours agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 17 hours agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 12 hours agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda By Reuters
Investing.com· 20 hours agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past...
Merck Beats on Earnings a Month After Major Drug Approval. The Stock Is Rising.
Barrons.com· 17 hours agoFEATURE Sales of Merck ‘s blockbuster cancer drug Keytruda jumped 20% in the first quarter of the...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 15 hours agoPharmaceutical segment revenues beat the Zacks Consensus Estimate of $13.53 billion and our model...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 2 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows ...
British patients test world’s first personalised mRNA jab for melanoma
PA Media: Science via Yahoo News· 3 hours agoPhase 2 data, published in December, found that people with serious high-risk melanomas who received...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 11 hours agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 20 hours agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Ads
related to: Keytruda
